During the development of endotoxemia, LPSs bind to toll-like receptor 4 (TLR4) and increase the concentration of inflammatory markers such as IL-1α, IL-6, INF-γ, and TNF-α (38), and consequently systemic chronic intestinal inflammation may develop. Here, IL6 is linked to serum lipopolysaccharide activity.